Hawraa Dheyaa Rasool (1), Fadyia Mahdi Muslim Alameedy (2)
Three of Human samples from 100 samples of human Coxsakievirus, Adenovirus B1. Coronavirus were collected during October, 1st, 2021 to 8 of December 2021. Human Coxsakievirus, Adenovirus B1, Coronavirus were including (1month – 95 years). The qPCR method was detected of three samples, for sequence diagnosis the results showed Coxsakievirus (98.38%), Adenovirus B1 (95%), Coronavirus (80%) cases. The Population groups studied samples subject groups were distribution into (6) groups including (1month,1-15, 16-31 and 32-47 and 48-63 and 64-79 and 80-95) year, changed age too gender. The samples were isolated from the hospitals including (Al-Sadr, AL- Hakeem, AL- Sajjad). The first study in Iraq to diagnose of human Coxsakievirus, Adenovirus B1, Coronavirus with Myocarditis.
[1] G. Anja, H. Ahmet, H. Lisanne, K. Jens, and F. Henry, "Coxsackievirus B3—Its Potential as an Oncolytic Virus," Viruses, vol. 13, p. 718, 2021.
[2] Z. Han, Y. Zhang, K. He, J. Wang, H. Tang, Y. Sun, Q. Yang, D. Yang, S. Zhang, M. Yang, X. Wang, and W. Xu, "Two Coxsackievirus B3 outbreaks associated with hand, foot, and mouth disease in China and the evolutionary history worldwide," BMC Infectious Diseases, vol. 19, p. 466, 2019.
[3] M. Scagnolari, L. Capobianchi, C. Trento, A. Bordi, C. Rozera, I. Ginevra, E. Galliano, L. Lalle, L. Ippolito, and A. Bartoloni, "Enteroviral Infections in the First Three Months of Life," Pathogens, vol. 11, p. 60, 2022.
[4] K. Shermila and K. Suresh, "Adenovirus Core Proteins: Structure and Function," Viruses, vol. 13, p. 388, 2021.
[5] A. Arnold and E. MacMahon, "Adenovirus infections," Medicine, 2017.
[6] R. Kaur, S. Sharma, G. Thakur, P. Singh, and J. Rani, "COVID-19: Pharmacotherapeutic insights on various curative approaches in terms of vulnerability, comorbidities, and vaccination," Inflammopharmacology, 2022.
[7] B. Zhang, S. Kobayashi, A. Kuroda, and M. Fujita, "COVID‐19 pathogenesis, prognostic factors, and treatment strategy: Urgent recommendations," Journal of Medical Virology, vol. 93, pp. 2694–2704, 2021.
[8] A. Trzoska, K. Owczarek, A. Lasek, R. Mazur, M. Matusiak, A. Kowalczyk, A. Borawska, K. Jarzyna, G. Osuchowski, and M. Górny, "Myocarditis and inflammatory cardiomyopathy in 2021: an update," Polish Archives of Internal Medicine, vol. 131, no. 6, 2021.
[9] C. Loewe, E. Bonelli, E. Basha, N. Brunner, C. Pöttler, J. Hübler, K. Müller, and S. Aschauer, "Cardiovascular Magnetic Resonance in Myocarditis," Diagnostics, vol. 12, p. 399, 2022.
[10] I. Gdoura, S. Rachdi, R. Hamza, T. Huber, K. Boussetta, A. Ben Ahmed, S. Hachicha, and M. Abdellatif, "Coxsackievirus B detection in cases of myocarditis, myopericarditis, pericarditis and dilated cardiomyopathy in hospitalized patients," Molecular Medicine Reports, vol. 10, pp. 2811–2818, 2014.
[11] N. Eisenstein, J. Ni, D. Lee, M. Pankuweit, H.-P. Schultheiss, R. Morimoto, J. Hare, T. Bold, K. Rasmussen, and J. Aron, "Detection of Viruses in Myocardial Tissues by Polymerase Chain Reaction: Evidence of Adenovirus as a Common Cause of Myocarditis in Children and Adults," J. Am. Coll. Cardiol., vol. 42, no. 3, 2003.
[12] E. Kogan, Y. Bykov, O. Borisova, A. Kuznetsova, L. Sidorova, E. Golubev, and A. Emelyanov, "Morphologically, immunohistochemically and PCR proven lymphocytic viral peri-, endo-, myocarditis in patients with fatal COVID-19," Diagnostic Pathology, vol. 17, p. 31, 2022.
[13] O. Valdés, B. Acosta, A. Pérez, C. Sánchez, A. González, G. Guerrero, G. González, L. Pérez, L. Silva, M. López, P. Álvarez, D. Rodríguez, V. Kourí, M. González, A. Lemos, I. Cuesta, and M. P. Pérez, "First Report on Fatal Myocarditis Associated With Adenovirus Infection in Cuba," Journal of Medical Virology, vol. 80, pp. 1756–1761, 2008.
[14] D. Egas, J. Jiménez, B. Palacios-Vélez, M. Barba, S. Maldonado, S. Chávez, J. Loor, F. Ramos, G. Escobar, M. García, V. Baque, P. Ruales-Salazar, and P. Castillo, "SARS-CoV-2 detection and sequencing in heart tissue associated with myocarditis and persistent arrhythmia: A case report," IDCases, vol. 25, p. e01187, 2021.
[15] F. M. M. Alameedy, "Sequences of S-surface of Human COVID-19," Journal of Pharmaceutical Research International, vol. 33, no. 60B, pp. 2572–2576, 2021.
[16] F. M. M. Alameedy, "Isolation and Molecular Study of Human Adenovirus," Proc. 2nd Int. Sci. Conf. Life Sciences, Faculty of Education for Women, University of Kufa, pp. 223–229, 2016.
[17] F. M. M. Alameedy et al., "Diagnosis of Human Coxsackievirus, Adenovirus and COVID-19 Virus Association Myocarditis by RT-PCR," Virology & Mycology, vol. 11, no. 6, pp. 1–4, 2022.